Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-01

Clinical Trial Update: Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism [Phase 3]

View source ↗

Summary

Phase 3 study assessing the effect of enclomiphene citrate on bone mineral density in men with secondary hypogonadism; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enclomiphene Citrate (enclomiphene citrate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Effect of Treatment on Bone Mineral Density | Phase 3 | Status: COMPLETED